Triptorelin

A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men. (NCI04)/NCI-GLOSS Definition: A drug that is used to treat advanced prostate cancer, and is being studied in the treatment of breast cancer. It belongs to the family of hormonal drugs called gonadotropin-releasing hormone analogs.

http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Triptorelin_castration

曲普瑞林

A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men. (NCI04)/NCI-GLOSS Definition: A drug that is used to treat advanced prostate cancer, and is being studied in the treatment of breast cancer. It belongs to the family of hormonal drugs called gonadotropin-releasing hormone analogs.

Triptorelin

ProstateCancer:Triptorelin_castration

Triptorelin

NCI Thesaurus Code:C1267

TRIPTORELIN

6-D-Tryptophan-LH-RH

Triptorelin

Detryptoreline

triptorelin

6-D-Tryptophanluteinizing Hormone-releasing Factor

AY-25650

CL-118,532

Decapeptyl

https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1267

http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Medical_castration